IEB Pharma

WELCOME TO : IEB Pharma

Tagrix 80 mg, containing the active ingredient Osimertinib, is a groundbreaking medication used in the treatment of non-small cell lung cancer (NSCLC). Manufactured by IEB Pharma, Tagrix is specifically designed to target tumors with specific mutations in the epidermal growth factor receptor (EGFR) gene, notably the T790M mutation, which is associated with resistance to other EGFR inhibitors.




bus rental services
Webbaniya.com - B2B MarketPlace

Tagrix 80 mg, containing the active ingredient Osimertinib, is a groundbreaking medication used in the treatment of non-small cell lung cancer (NSCLC). Manufactured by IEB Pharma, Tagrix is specifically designed to target tumors with specific mutations in the epidermal growth factor receptor (EGFR) gene, notably the T790M mutation, which is associated with resistance to other EGFR inhibitors.



 


Disclaimer:
Any content posted by users, including but not limited to text, images, videos, or other media, is the sole responsibility of the user who provided it. The platform does not claim ownership of user-submitted content and does not verify its copyright status.

By posting content, users affirm that they have the necessary rights, licenses, or permissions to share the material. If you believe that any content infringes upon your copyright, please contact us with the necessary details, and we will take appropriate action in accordance with applicable laws.

This platform is not responsible for any copyright violations committed by users. Users are advised to ensure compliance with copyright laws when sharing content.

New Products / Services

  • 1743937894.jpg
    06 April

    Goexch9

    Join Goexch9 and explore a world of sports betting options, including cricket, football, and more. Bet with confidence o

    New Delhi , India


Product Catagories




Full Name:
Company Name:
Country:
Email Address:
Tel / Mobile No.:
Website:
Please Explain: